Diagnostic performance of 68Ga-DOTATOC PET/CT in tumor-induced osteomalacia

Volume: 35, Issue: 3, Pages: 397 - 405
Published: Feb 13, 2021
Abstract
Tumor-induced osteomalacia (TIO) is caused by typically small tumors that secrete fibroblast growth factor 23 (FGF23). As tumor resection is the only effective treatment for TIO, it is important to detect the culprit tumor. We aimed to assess the utility of 68Gallium-DOTA-D-Phe(1)-Tyr(3)-octreotide (68Ga-DOTATOC) PET/CT in TIO and the correlation between biochemical parameters and the PET/CT results. Thirty-five patients with clinically...
Paper Details
Title
Diagnostic performance of 68Ga-DOTATOC PET/CT in tumor-induced osteomalacia
Published Date
Feb 13, 2021
Volume
35
Issue
3
Pages
397 - 405
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.